论文部分内容阅读
目的:探究对于肺癌患者而言肿瘤标志物在临床诊断中所具有的重要意义。方法:择取2014年12月到2016年12月期间于笔者所在医院治疗肺癌的40例患者,设其为研究组;择取同期于笔者所在医院进行生化检验的40例健康受检者,设其为对照组。为两组患者进行肿瘤标志物检验,并对比两组患者在检验结果上存在的差异。结果:两组患者在癌胚抗原(CEA)、糖类抗原153(CA153)、糖类抗原125(CA125)、神经特异性烯醇化酶(NSE)、细胞角蛋白21-1片段(CYFRA12-1)这五种肿瘤标志物的检测结果上有着鲜明的不同,研究组上述各项指标的检测结果均高于对照组,差异有统计学意义(P<0.05)。结论:使用NSE、CEA、CA125、CA153、CYFRA12-1等肿瘤标志物可以实现对肺癌的准确诊断。
Objectives: To explore the significance of tumor markers in the clinical diagnosis of lung cancer patients. Methods: Forty patients with lung cancer who were treated in the author’s hospital from December 2014 to December 2016 were enrolled as study group, 40 healthy subjects undergoing biochemical tests in the same hospital at the same time, It is a control group. The two groups of patients for tumor marker test, and compared the two groups of patients in the test results on the differences. Results: The CEA, CA153, CA125, NSE, CYFRA12-1 There are distinct differences between the detection results of the five tumor markers. The test results of the above indexes in the study group are all higher than those in the control group, and the difference is statistically significant (P <0.05). Conclusion: The accurate diagnosis of lung cancer can be achieved by using tumor markers such as NSE, CEA, CA125, CA153 and CYFRA12-1.